Europharma Research & Science Center is an independent Contract Research Organization (CRO) specializing in pharmacoepidemiology, real-world evidence (RWE), and clinical trials. We support pharmaceutical, biotechnology and medical device companies throughout the entire lifecycle of medicinal products by designing, conducting and reporting high-quality studies in accordance with GVP, ICH-GCP, MDR, ISO 14155 and applicable European regulatory requirements.
Our scientific expertise includes Post-Authorisation Safety Studies (PASS), Post-Authorisation Efficacy Studies (PAES), Drug Utilisation Studies (DUS), NIS, RWE projects, clinical studies of medical devices, and clinical trials. We also conduct toxicological and preclinical research in collaboration with accredited scientific partners (GLP), providing comprehensive scientific and regulatory support from protocol development through statistical analysis, final reporting and publication. In addition to CRO services, we operate our own physician-led clinical research site, integrating clinical practice with research excellence and enabling efficient patient recruitment, high-quality source documentation, and rigorous study conduct across a broad range of therapeutic areas. This integrated CRO and site model enables seamless execution of research projects, combining scientific expertise, regulatory excellence and direct access to study participants within a single organization.
As a member of the EFPIA Partners in Research community, we are committed to promoting scientific excellence, methodological rigor, transparency, and the generation of robust evidence supporting regulatory decision-making and patient safety.
Our mission is to bridge science, clinical practice and regulatory requirements by delivering high-quality research that meets the highest international standards of scientific integrity and patient protection.